SCHEMBL1676791

SCHEMBL1676791

O=[C]CCCCCCCCCCCCCCCCCC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1677085 1.00
SCHEMBL2153961 1.00
SCHEMBL7782903 1.00
SCHEMBL1676891 1.00
SCHEMBL2153675 1.00
SCHEMBL2155118 1.00
SCHEMBL2155057 1.00
SCHEMBL2154219 1.00
SCHEMBL2153937 1.00
SCHEMBL2154801 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190112348-A1 PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES NOVO NORDISK AS (DK) 2019-04-18 US claimed
US-10259856-B2 Protease stabilized acylated insulin analogues NOVO NORDISK A/S (DK) 2019-04-16 US claimed
US-9688737-B2 Protease stabilized acylated insulin analogues NOVO NORDISK A/S (DK) 2017-06-27 US claimed
EP-2254906-B1 PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES NOVO NORDISK AS (DK) 2016-10-05 EP claimed
EP-2910571-A1 Protease stabilized, acylated insulin analogues Novo Nordisk A/S (DK) 2015-08-26 EP claimed
US-20150210748-A1 PROTEASE STABILIZED ACYLATED INSULIN ANALOGUES NOVO NORDISK AS (DK) 2015-07-30 US claimed
US-20150210747-A1 PROTEASE STABILIZED ACYLATED INSULIN ANALOGUES NOVO NORDISK AS (DK) 2015-07-30 US claimed
US-20110105720-A1 PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES NOVO NORDISK A/S (DK) 2011-05-05 US claimed
EP-2254906-A1 PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES Novo Nordisk A/S (DK) 2010-12-01 EP claimed
WO-2009115469-A1 PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES NOVO NORDISK A/S (DK) 2009-09-24 WO claimed
CN-116789801-A Novel insulin derivatives and uses thereof 南京赛诺生物技术有限公司 2023-09-22 CN disclosed
US-20190112348-A1 PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES NOVO NORDISK AS (DK) 2019-04-18 US disclosed
US-10259856-B2 Protease stabilized acylated insulin analogues NOVO NORDISK A/S (DK) 2019-04-16 US disclosed
EP-3184171-B1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2019-03-20 EP disclosed
US-10144752-B2 Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-04 US disclosed
WO-2009022013-A1 INSULIN ANALOGUES WITH AN ACYL AND AKLYLENE GLYCOL MOIETY NOVO NORDISK A/S (DK) 2009-02-19 WO disclosed
WO-2009022005-A1 INSULIN ANALOGUES WITH AN ACYL AND ALKYLENE GLYCOL MOIETY NOVO NORDISK A/S (DK) 2009-02-19 WO disclosed
US-4413076-A Polyalkylpiperdine side chain stabilizers for synthetic polymer compositions SANKYO COMPANY LTD. (JP) 1983-11-01 US disclosed
EP-0001835-B1 POLYMERS SUBSTITUTED WITH POLYALKYLPIPERIDINE SIDE CHAINS, PREPARATION AND USE THEREOF AS STABILIZERS SANKYO COMPANY LIMITED (JP) 1981-08-12 EP disclosed
EP-0001835-A2 Polymers substituted with polyalkylpiperidine side chains, preparation and use thereof as stabilizers SANKYO COMPANY LIMITED (JP) 1979-05-16 EP disclosed